
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Veterinary wellness plans can be a terrific strategy for improving patient health. Consider these important issues with your team before choosing a plan.





